Upfront Cabozantinib for Advanced RCC Improves Outcomes
Cabozantinib reduced the risk of disease progression or death compared with sunitinib among patients with previously untreated advanced renal cell carcinoma.
Print Issue: October 03, 2017
Early NLR Changes Predict mRCC Immunotherapy Outcomes
Rises and decreases in neutrophil-to-lymphocyte ratio at 6 weeks after treatment with anti-PD-1/PD-L1 immune checkpoint blockade is associated with progression-free and overall survival.
Arteriovenous Fistulas Not Always the Best Option
Despite low infection rates, AVFs have a high risk of maturation failure and abandonment.
Prostate Cancer Screening Saves Lives, New Analysis Shows
A European trial found a survival benefit from PCa screening and a US trial did not, but a new analysis finds that both trials provide compatible evidence that screening decreases PCa mortality.
Drug Approved for Complicated Urinary Tract Infections
Vabomere, which combines meropenem and vaborbactam, demonstrated superior efficacy to piperacillin/tazobactam.
Liraglutide Linked With Lower Diabetic Kidney Disease Risk
Liraglutide-treated patients were 22% less likely than placebo recipients to experience a composite outcome of renal events.
AKI After Computed Tomography Not Tied to Contrast
AKI occurred with similar frequency among patients who did and did not receive contrast medium.
Metoprolol Increases Uric Acid, Risk of Gout
In a study of African Americans with hypertension-related CKD, metoprolol, but neither ramipril nor amlodipine, increased serum uric acid levels.
Study Finds No Link Between Marijuana Use and Kidney Function
No significant association found between marijuana use and change in estimated glomerular filtration rate or development of albuminuria.
Cancer Drug Slows ADPKD Cyst Growth, Study Finds
Bosutinib treatment was associated with a 66% decrease in the annual rate of kidney enlargement.
-
Loading...
-
Loading...
